title: Non-Hodgkin's lymphoma in patients with glioma treated with temozolomide.
authors.forename: Bart
authors.initials: B
authors.lastname: Neyns
authors.forename: Susanna
authors.initials: S
authors.lastname: Cordera
authors.forename: Eric
authors.initials: E
authors.lastname: Joosens
authors.forename: Nader
authors.initials: N
authors.lastname: Pouratian
authors.forename: Pouratian
authors.initials: P
authors.lastname: Nader
mesh_terms: D000818:Animals; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003606:Dacarbazine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D004334:Drug Administration Schedule; D005260:Female; D005910:Glioma / Q000188:drug therapy*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000139:chemically induced*; D051379:Mice; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D018570:Risk Assessment; D000077204:Temozolomide
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide